Jenkem Technology Co

Jenkem Technology Co EV/OCF

The EV/OCF (Enterprise Value to Operating Cash Flow) of Jenkem Technology Co (688356.SS) as of Oct 31, 2026 is 74.78. In the previous year, EV/OCF (Enterprise Value to Operating Cash Flow) was 44.97 — a change of 66.29% (higher).

EV/OCF

74.78

YoY

66.29%

Last updated:

EV/OCF (Enterprise Value to Operating Cash Flow) of Jenkem Technology Co is 2025 74.78 . EV/OCF (Enterprise Value to Operating Cash Flow) of Jenkem Technology Co was 2024 44.97 . It decreases by 66.29% higher compared to the previous year.

The Jenkem Technology Co EV/OCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/OCF
Date
EV/OCF
Jan 1, 2018
174.41 CNY
Jan 1, 2019
114.62 CNY
Jan 1, 2020
66.92 CNY
Jan 1, 2021
45.11 CNY
Jan 1, 2022
29.04 CNY
Jan 1, 2023
45.38 CNY
Jan 1, 2024
44.97 CNY
Jan 1, 2025
74.78 CNY
The Jenkem Technology Co EV/OCF history
YEAREV/OCFYoY
74.78+66.29%
44.97-0.90%
45.38+56.29%
29.04-35.63%
45.11-32.59%
66.92-41.62%
114.62-34.28%
174.41-36.81%
276.03-30.08%
394.79—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Jenkem Technology Co Stock analysis

What does Jenkem Technology Co do? Jenkem Technology Co., Ltd. generates revenue through the research, development, production, and sales of medical polyethylene glycol (PEG) and its active derivatives. The company's primary products are sold to pharmaceutical companies, research institutions, and medical device manufacturers that use these materials in drug development and production. Technical services such as patent and non-patent technology licensing, as well as R&D services, also contribute to the company's income. The firm's customer segments include entities involved in drug research, development, and production, as well as scientific research organizations. The company's business model focuses on providing specialized materials and technical support for the medical and pharmaceutical sectors. Medical polyethylene glycol and its active derivatives serve as critical components in various medical applications, driving demand from industry partners. By offering both physical products and intellectual property services, Jenkem Technology diversifies its revenue streams within the healthcare technology space. Jenkem Technology Co., Ltd. operates with a clear focus on the medical and pharmaceutical industries, targeting clients that require high-quality PEG-based materials for their research and manufacturing processes. The company's technical services, including licensing and R&D support, further strengthen its position as a supplier of essential materials and solutions in the healthcare sector. Jenkem Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Jenkem Technology Co stock

EV/OCF (Enterprise Value to Operating Cash Flow) of Jenkem Technology Co is 74.78 in 2025.

EV/OCF (Enterprise Value to Operating Cash Flow) of Jenkem Technology Co changed from 44.97 to 74.78, representing a 66.29% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/OCF (Enterprise Value to Operating Cash Flow) Jenkem Technology Co since 2006 – with annual values, charts, and detailed analysis.

EV/OCF compares enterprise value to operating cash flow, measuring how much investors pay per unit of cash generated from operations.

To evaluate EV/OCF (Enterprise Value to Operating Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/OCF (Enterprise Value to Operating Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/OCF (Enterprise Value to Operating Cash Flow)'s Jenkem Technology Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Jenkem Technology Co

All Key Metrics — Jenkem Technology Co